STALLION Stallion India Fluorochemicals Q4 FY25 results (Jan–Mar 2025) and concall
Stallion India Fluorochemicals Ltd. delivered strong Q4 FY25 results, driven by robust demand and strategic execution, with significant QoQ growth in revenue, EBITDA, and PAT. The company is focused on forward integration and expansion into high-margin segments like semiconductor gases and HFOs, targeting a 30-35% CAGR over the next three years. While CapEx deployment saw initial delays due to redesigning and strong sales focus, new facilities are on track for completion by October 2025, setting the stage for future growth.
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
What they filed
| Line item | Q2 FY25 | Q3 FY25 | Q4 FY25 |
|---|---|---|---|
| Revenue | 68 | 85 | 152 |
| EBITDA | 2 | 14 | 19 |
| Net profit | 1 | 10 | 13 |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.
